Engineered Endolysin-Based “Artilysins” To Combat Multidrug-Resistant Gram-Negative Pathogens

Cited by papers we hold 14

• The Mechanism of Bacterial Resistance and Potential Bacteriostatic Strategies · 2022
  No notice
• Endolysin, a Promising Solution against Antimicrobial Resistance · 2021
  No notice
• Phage-Encoded Endolysins · 2021
  No notice
• Acinetobacter baumannii Resistance: A Real Challenge for Clinicians · 2020
  No notice
• Bacteriophages in Natural and Artificial Environments · 2019
  No notice
• The Preclinical and Clinical Progress of Bacteriophages and Their Lytic Enzymes: The Parts are Easier than the Whole · 2019
  No notice
• The Concept of an Ideal Antibiotic: Implications for Drug Design · 2019
  No notice
• Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application? · 2018
  No notice
• Phage-Derived Peptidoglycan Degrading Enzymes: Challenges and Future Prospects for In Vivo Therapy · 2018
  No notice
• Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options · 2017
  No notice
• Bacteriophage-encoded virion-associated enzymes to overcome the carbohydrate barriers during the infection process · 2017
  No notice
• Structural and Enzymatic Characterization of ABgp46, a Novel Phage Endolysin with Broad Anti-Gram-Negative Bacterial Activity · 2016
  No notice
• Antimicrobial Peptides: An Emerging Category of Therapeutic Agents · 2016
  No notice
• Bacteriophages as Weapons Against Bacterial Biofilms in the Food Industry · 2016
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.